Your topics. New publications.

A compact browser notification when there’s something new. At most once a day — no account needed.

What interests you?

Optional and switchable off here at any time. We save your selected topics and device subscription; no email address is required. Privacy

Search the harborEN/DEAccount
Video library· Dr. William Wallace

NAD Wars: NMN vs NR in the Aging Battle

Thumbnail from YouTube. Playing loads the YouTube player.

History & recommendationsOff

Keep recently viewed content on this browser. Your history stays on this device and is never sent to Harbor. Videos you play can also help order related video recommendations.

Up to 120 items · 90 days. Turning this off deletes the history.
Open saved items & history →

About this video

Creator description · original language

In this episode of Daily Value, we look inside the NAD+ wars - breaking down the science, the hype, and the controversy surrounding Nicotinamide Riboside (NR) and Nicotinamide Mononucleotide (NMN). These two molecules have been promoted as keys to longevity, but the story is far more complex. We’ll look at the biochemistry of NAD+ metabolism, compare what the research really says about NR and NMN, and dig into the regulatory drama that’s shaped their (NMN’s) availability. Most importantly, we’'ll look at a bigger-picture strategy for restoring NAD+, one that goes beyond precursors alone. PMID: 35134387 PMID: 39026037 doi:10.1002/fft2.511 00:00 the NAD Wars 01:02 Understanding NAD+ and Its Importance 04:14 Challenges and Regulatory Issues with NMN and NR 05:44 Clinical Research and Safety Profiles 07:13 Complexities in Boosting NAD+ Levels 09:04 Multi-Targeted Strategies for NAD+ Restoration 13:25 Conclusion: Embracing Complexity in Aging https://www.instagram.com/dr.williamwallace/ https://www.facebook.com/williamwallacePhD https://twitter.com/williamwallace https://www.linkedin.com/in/drwilliamwallace/

Dr. William Wallace · 14 min · Source published: 2025-05-23

Added to Harbor: 10/22/2026

Original on YouTube ↗

Automatically categorized source. Creator statements are not an independent evidence review or personal medical guidance.

Discussion

Community discussions

0 topics

Member contributions. Share sources, disclose commercial interests, and avoid personal medical or dosing advice.

Loading…